
Giannis S. Mountzios
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 138 publications
Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 26, 2026
Ivonescimab in advanced squamous non-small-cell lung cancer: can we raise the survival bar?
Journal: Lancet (London, England)
Published: May 19, 2026
Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges.
Journal: The Lancet. Respiratory medicine
Published: May 09, 2026
Patient-reported outcomes with tarlatamab in extensive-stage small cell lung cancer after platinum-based chemotherapy: results from the phase 3 DeLLphi-304 trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 08, 2026
Tarlatamab in relapsed small-cell lung cancer: a DLL3-targeted bispecific T-cell engager.
Journal: Immunotherapy
Published: May 04, 2026
Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG study.
Journal: Cancer treatment and research communications
Published: March 17, 2026
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.
Journal: ESMO open
Published: March 10, 2026
PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes.
Journal: Cancer treatment reviews
Published: March 06, 2026
SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non-Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group Study.
Journal: JCO clinical cancer informatics
Published: February 03, 2026
Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.
Journal: Cancer research communications
Published: January 22, 2026
Artificial Intelligence in ALK-Rearranged NSCLC: Forecasting Response and Resistance.
Journal: Cancers
Published: January 22, 2026
Last Updated: 09/26/2026